N

North Sea group

7 employees

NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.

Basic info

Industry

transportation, logistics, supply chain and storage

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2017

Funding rounds raised

Total raised

$80M

from 18 investors over 18 rounds

N

North Sea group raised $80M on December 17, 2021

Investors: Ysios Capital, -, Hercules Capital, Inc., BGV (BioGeneration Ventures), Forbion, venBio Partners and Sofinnova Ventures, Russia technology fund

N

North Sea group raised $40M on January 8, 2020

Investors: Forbion, BGV (BioGeneration Ventures), venBio Partners, -, Novo Holdings and Sofinnova Ventures, Russia technology fund

N

North Sea group raised undisclosed on January 1, 2019

Investors: Sofinnova Ventures, Russia technology fund

N

North Sea group raised $29M on December 12, 2017

Investors: -, BGV (BioGeneration Ventures), Novo Holdings and Forbion

FAQ